Davidson Kempner Capital Management’s Alder Biopharmaceuticals ALDR Stock Holding History

Davidson Kempner Capital Management’s Portfolio ALDR Stock Details ALDR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-3,312,203	Closed	-$62.5M	–	220
2019 Q3	$62.5M	Buy	+3,312,203	New	+$37.9M	1.23%	11

Davidson Kempner Capital Management's ALDR Position: Q4 2019 in Review

Davidson Kempner Capital Management sold out of Alder Biopharmaceuticals (ALDR) in Q4 2019, closing a stake of 3,312,203 shares — an estimated $62.5M sold.

Davidson Kempner Capital Management first reported a position in ALDR in Q3 2019 and held it in 1 quarter. The position peaked at $62.5M in Q3 2019. 0 funds tracked by Wall St. Rank hold ALDR as of Q4 2019.

Davidson Kempner Capital Management reported no remaining Alder Biopharmaceuticals position as of Q4 2019 after selling out during the quarter.
Davidson Kempner Capital Management sold 3,312,203 Alder Biopharmaceuticals shares in Q4 2019, an estimated $62.5M.
Davidson Kempner Capital Management first reported a position in Alder Biopharmaceuticals in Q3 2019 and held it in 1 quarter.
Davidson Kempner Capital Management's Alder Biopharmaceuticals position peaked at $62.5M in Q3 2019.
0 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2019.

Based on Davidson Kempner Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.